耳鼻喉學科

Medicine and Dentistry

1. Cohort Analysis 100%
2. Squamous Cell Carcinoma 77%
3. Overall Survival 72%
4. Nasopharynx Carcinoma 67%
5. Oral Cavity 65%
6. Head and Neck Cancer 60%
7. Sensorineural Hearing Loss 59%
8. Oral Cancer 52%
9. Radiation Therapy 51%
10. Hazard Ratio 50%
11. Sialolithiasis 44%
12. Disease 43%
13. Case-Control Study 42%
14. Chemoradiotherapy 41%
15. Neck 40%
16. Malignant Neoplasm 38%
17. Obstructive Sleep Apnea 38%
18. Prognostic Factor 37%
19. Disease Specific Survival 37%
20. Otorhinolaryngology 36%
21. Odds Ratio 36%
22. Hearing Impairment 34%
23. Cochlear Implant 34%
24. Head and Neck Squamous Cell Carcinoma 32%
25. Survival Rate 32%
26. Meta-Analysis 32%
27. Tympanic Membrane 31%
28. Neoplasm 29%
29. Myringoplasty 29%
30. Medicine 27%
31. Diabetes Mellitus 27%
32. Mouth Squamous Cell Carcinoma 27%
33. Logistic Regression Analysis 26%
34. Tympanoplasty 25%
35. Statin 25%
36. Papillomavirus Infection 25%
37. Symptom 25%
38. Sialadenitis 24%
39. Prevalence 24%
40. Nasopharynx Cancer 24%
41. Salivary Gland 23%
42. Trachea 23%
43. Carcinoma Cell 22%
44. Allergic Rhinitis 22%
45. Retrospective Cohort Study 22%
46. Holmium 21%
47. Tonsillectomy 20%
48. Vocal Folds 20%
49. Subgroup Analysis 20%
50. Systematic Review 19%
51. Propensity Score Matching 19%
52. Parasympathetic Function 19%
53. Chronic Rhinosinusitis 19%
54. Smooth Muscle 19%
55. Nasal Packing 19%
56. Lithotripsy 19%
57. Programmed Cell Death 19%
58. Systemic Lupus Erythematosus 19%
59. Induction Chemotherapy 19%
60. Vestibular Disorder 19%
61. Tongue 19%
62. Cholesteatoma 18%
63. Proportional Hazards Model 18%
64. Neck Dissection 18%
65. COVID-19 17%
66. Outpatient 17%
67. Metastatic Carcinoma 17%
68. Ischemic Heart Disease 17%
69. Hyperlipidemia 17%
70. Decellularization 17%
71. Adjuvant Therapy 17%
72. Oropharyngeal Cancer 16%
73. Submandibular Gland 16%
74. P16 16%
75. Recurrent Disease 16%
76. Diabetes 15%
77. Upregulation 15%
78. Computer Assisted Tomography 15%
79. Apoplexy 15%
80. Cancer 15%
81. Clinical Examination 14%
82. Skull Base 14%
83. Cancer Registry 13%
84. Postoperative Pain 13%
85. Chronic Kidney Disease 13%
86. Carcinoma 13%
87. Retina Vein Occlusion 12%
88. Bell's Palsy 12%
89. Microtia 12%
90. Superoxide Dismutase 12%
91. Lipocortin 2 12%
92. Hypochromic Anemia 12%
93. Consonant 12%
94. Supplementation 12%
95. Lung Adenocarcinoma 12%
96. Nodular Melanoma 12%
97. Positron Emission Tomography-Computed Tomography 12%
98. Vardenafil 12%
99. Alzheimer's Disease 12%
100. Visual Impairment 12%

Pharmacology, Toxicology and Pharmaceutical Science

1. Cohort Study 94%
2. Perception Deafness 79%
3. Sleep Disordered Breathing 77%
4. Case-Control Study 50%
5. Nasopharynx Carcinoma 47%
6. Sialolithiasis 42%
7. Comorbidity 35%
8. Chemoradiation Therapy 35%
9. Mouth Cancer 33%
10. Ovalbumin 33%
11. Head and Neck Squamous Cell Carcinoma 32%
12. Malignant Neoplasm 32%
13. Respiratory Tract Allergy 32%
14. Statin (Protein) 32%
15. Nasopharynx Cancer 31%
16. Head and Neck Cancer 31%
17. Disease 30%
18. Diabetes Mellitus 27%
19. Overall Survival 27%
20. Mouth Squamous Cell Carcinoma 26%
21. Chronic Rhinosinusitis 25%
22. Sialoadenitis 24%
23. Chemotherapy 24%
24. Squamous Cell Carcinoma 23%
25. Vertigo 21%
26. Prevalence 20%
27. Mouse 20%
28. Guinea Pig 20%
29. Hesperetin 19%
30. Hearing Impairment 19%
31. Symptom 19%
32. Xylazine 15%
33. Ketamine 15%
34. Survival Rate 15%
35. Infection 14%
36. Rolipram 14%
37. Dimethyl Ether 14%
38. Methacholine 13%
39. Phosphodiesterase IV 13%
40. Papillomavirus Infection 12%
41. Thyroid Cancer 12%
42. Renal Cell Carcinoma 12%
43. HIV 12%
44. Phosphodiesterase 12%
45. Rhinosinusitis 12%
46. Sleep Disorder 12%
47. Systemic Lupus Erythematosus 12%
48. 2,5-Dimethoxy-4-iodoamphetamine 12%
49. Pig 12%
50. Adverse Event 12%
51. Biological Marker 11%
52. Cholesteatoma 11%
53. Retrospective Study 11%
54. Hyperlipidemia 11%
55. Paclitaxel 11%
56. Cholelithiasis 11%
57. Disease Specific Survival 10%
58. Heart Infarction 10%
59. Neoplasm 10%
60. Erectile Dysfunction 9%
61. Therapeutic Window 9%
62. Coronavirinae 9%
63. Rabbit Model 9%
64. Tinnitus 9%
65. Ischemic Heart Disease 8%
66. Cancer Registry 8%
67. Chronic Kidney Failure 8%
68. Sjoegren Syndrome 8%
69. Prostate Cancer 8%
70. Salivary Gland Disease 8%
71. SARS Coronavirus 8%
72. Inflammation 8%
73. Binding Site 8%
74. Prospective Cohort Study 8%
75. Carcinoma 8%
76. Traditional Chinese Medicine 7%
77. Asthma 7%
78. Heme Oxygenase 1 7%
79. Antihistaminic Agent 7%
80. Placebo 7%
81. Mortality Rate 7%
82. Cisplatin 7%
83. Sudden Deafness 7%
84. Foreign Body 7%
85. Hesperidin 7%
86. Distant Metastasis 7%
87. Cytokine 7%
88. Observational Study 7%
89. Hypercholesterolemia 7%
90. Receptor 7%
91. Chronic Obstructive Lung Disease 7%
92. Syndrome 7%
93. Pandemic 7%
94. Interleukin 4 7%
95. Randomized Controlled Trial 7%
96. IC50 6%
97. Phosphodiesterase IV Inhibitor 6%
98. Phosphodiesterase I 6%
99. Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 6%
100. Recurrent Disease 6%